ALC is a highly bioavailable form of L-Carnitine that can cross the blood-brain barrier, where it helps to manage oxidative damage, supports mitochondrial function and helps to maintain normal neurotransmitter activity
What could be better than clear, glowing skin and rejuvenation delivered right to your front door?
doi: 10.1016/j.biopha.2024.116553 162 PengSLuXLinFMaoNYuLZhuTet al
Quick Answer: Current limited evidence does not suggest GLP-1 agonists directly worsen Crohn's disease, but their gastrointestinal side effects may complicate symptom monitoring and disease assessment
Figure 1 In line with these observations, weight loss has emerged not only as a supportive strategy but also as a disease-modifying intervention in PsA ( Preclinical studies further suggest that GLP-1RAs may modulate key cytokine pathways implicated in psoriatic disease, including NF-B, IL-6, IL17, and IL23, while small clinical studies have reported improvements in skin disease severity in PsO ( This narrative review summarizes the current clinical evidence on GLP-1RAs in PsO and PsA and discusses future research directions aimed at evaluating their potential role in intercepting PsA development and improving outcomes in patients with complex immunometabolic profiles